Published online before print June 5, 2008

This Article Full Text (Rapid PDF) All Versions of this Article: ajpath.2008.071123v1 173/1/42    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by De Paepe, M. E. Articles by Mao, Q. PubMed PubMed Citation Articles by De Paepe, M. E. Articles by Mao, Q.

Copyright © 2008 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2008.071123

Accepted for publication April 8, 2008.

Article

Fas-Ligand-Induced Apoptosis of Respiratory Epithelial Cells Causes Disruption of Postcanalicular Alveolar Development

Monique E. De Paepe^*@, Sravanthi Gundavarapu^*, Umadevi Tantravahi^*, John R. Pepperell^*, Sheila A. Haley, Francois I. Luks^¶||, and Quanfu Mao^*

From the Departments of Pathology,* and Pediatrics, Women and Infants Hospital; the Division of Pediatric Surgery, Rhode Island Hospital, Providence; and the Departments of Pathology and Laboratory Medicine, Pediatrics,^¶ and Surgery,^|| Alpert Medical School of Brown University, Providence, Rhode Island

^@ To whom correspondence should be addressed. E-mail: mdepaepe{at}wihri.org.

	Abstract

Premature infants are at risk for bronchopulmonary dysplasia, a complex condition characterized by impaired alveolar development and increased alveolar epithelial apoptosis. The functional involvement of pulmonary apoptosis in bronchopulmonary dysplasia- associated alveolar disruption remains undetermined. The aims of this study were to generate conditional lung-specific Fas-ligand (FasL) transgenic mice and to determine the effects of FasL-induced respiratory epithelial apoptosis on alveolar remodeling in postcanalicular lungs. Transgenic (TetOp)₇-FasL responder mice, generated by pronuclear microinjection, were bred with Clara cell secretory protein (CCSP)-rtTA activator mice. Doxycycline (Dox) was administered from embryonal day 14 to postnatal day 7, and lungs were studied between embryonal day 19 and postnatal day 21. Dox administration induced marked respiratory epithelium-specific FasL mRNA and protein up-regulation in double-transgenic CCSP-rtTA⁺/(TetOp)₇-FasL⁺ mice compared with single-transgenic CCSP-rtTA⁺ littermates. The Dox-induced FasL up-regulation was associated with dramatically increased apoptosis of alveolar type II cells and Clara cells, disrupted alveolar development, decreased vascular density, and increased postnatal lethality. These data demonstrate that FasL-induced alveolar epithelial apoptosis during postcanalicular lung remodeling is sufficient to disrupt alveolar development after birth. The availability of inducible lung-specific FasL transgenic mice will facilitate studies of the role of apoptosis in normal and disrupted alveologenesis and may lead to novel therapeutic approaches for perinatal and adult pulmonary diseases characterized by dysregulated apoptosis.

This article has been cited by other articles:

				Q. Mao, S. Gundavarapu, C. Patel, A. Tsai, F. I. Luks, and M. E. De Paepe The Fas System Confers Protection against Alveolar Disruption in Hyperoxia-Exposed Newborn Mice Am. J. Respir. Cell Mol. Biol., December 1, 2008; 39(6): 717 - 729. [Abstract] [Full Text] [PDF]